Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...

One big name in Napa Valley wine is trying its hand at modernizing, and they’re leaning into one of its winemaker’s artsy, ...

Communiqué de la société OXURION du 18/03/2025 - Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO ...

Access the CEO Connect segment hereLA JOLLA, CA, March 18, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a ...

Cloud-based Elite™ platform to roll out to Roche's laboratory network across 50+ countries and a target 1,000 installations over five years.

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Real estate developer Alameda claimed bio-tech entrepreneur Patrick Soon-Shiong and lease guarantor NantMedia breached the ...

PEP-010, PEP-Therapy’s first-in-class bifunctional therapeutic peptide is being studied in an ongoing Phase Ib clinical trial evaluating safety, tolerability, pharmacokinetics and preliminary ...

Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody ® Pipeline and Platform ...

I Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology ...

Nearly two hours into the University Community Planning Group’s March 11 meeting, a decision on a large proposed development ...